SAN DIEGO--(BUSINESS WIRE)--July 26, 2006--Illumina, Inc.(NASDAQ:ILMN) announced today that Jay Flatley, President and CEO,will be presenting at the upcoming Baird 2006 Focus on OncologyConference in New York City, New York (USA).
Mr. Flatley's presentation will be webcast live beginning on orabout 3:50 p.m. Eastern Time (ET) on Wednesday, August 2, 2006. Thefollowing webcast URL provides access to the live presentation as wellas an audio file that will be archived following the event:http://www.wsw.com/webcast/rwbaird15/ilmn/.
Illumina (www.illumina.com) is developing next-generation toolsthat permit large-scale analysis of genetic variation and function.The Company's proprietary BeadArray(TM) technology -- now used inleading genome centers around the world -- provides the throughput,cost effectiveness and flexibility to enable researchers in the lifesciences and pharmaceutical industries to perform the billions oftests necessary to extract medically valuable information fromadvances in genomics and proteomics. This information will help pavethe way to personalized medicine by correlating genetic variation andgene function with particular disease states, enhancing drugdiscovery, allowing diseases to be detected earlier and morespecifically, and permitting better choices of drugs for individualpatients.
CONTACT: Illumina, Inc.
Jay Flatley, 858-202-4501
jflatley@illumina.com
or
William Craumer, 858-202-4667
bcraumer@illumina.com
SOURCE: Illumina, Inc.